Research Article

Physicochemical Characterization of In Vitro LDL Glycation and Its Inhibition by Ellagic Acid (EA): An In Vivo Approach to Inhibit Diabetes in Experimental Animals

Figure 8

(a) CML detection in native, AGE-LDL- and AGE-LDL EA-treated samples in vitro. (b) Group I normal control, group II diabetic control and group II-IV was 10 and 20 mg EA-treated diabetic rats. Each value is for three experiments. The and values differ significantly with diabetic group II rats.
(a)
(b)